Abstract:The current issue of the Journal contains the European Urinalysis Guideline (EUG) 2023 written and edited by the Task and Finish Group Urinalysis (TFG-U), working under the Science Committee of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM). It is an update to the previous European Urinalysis Guideline published by the European Confederation of Laboratory Medicine (ECLM) in 2000 [1, 2]. After more than 20 years, these guidelines needed to be updated at least with respect to new diagnostic markers and infectious agents, development of automated particle counting, current tools of specimen collection, quality control processes and analytical performance specifications. Two crucial features are important in this updated guideline: It remains a laboratory process-oriented guideline as opposed to the most medical guidelines describing clinical perspectives of diagnostic procedures, It is an expression of fruitful co-operation between clinical chemistry and clinical microbiology laboratories since a shared single-voided urine specimen is discussed from professional knowledge of both clinical laboratory disciplines. The comprehensive document is published in seven sections covering different areas and techniques of urinalysis, with two detailed Annexes. The text describes shared test requisition strategies, preanalytical procedures, and partially even shared interpretation of analytical results. Examinations include chemical measurements with strip tests and quantitative procedures, and urine bacterial cultures with identification of species and antimicrobial susceptibility tests. Urine particle analysis represents a shared expertise, organised in either clinical chemistry or clinical microbiology laboratories in different European countries, or occasionally still performed by the nephrologists themselves. Combination of these examinations into a shared diagnostic process allows optimisation of routine urinalysis and urine bacterial culture, while specific procedures and examinations are needed in specific cases and specimens. The EFLM EUG 2023 contains numerous improvements compared to the previous ECLM guideline in 2000: The collected literature was structured based on the GRADE principles to provide levels of evidence (A–D) and strengths (1–2) to the given recommendations for laboratory tests [3, 4], as described in detail in the Introduction of the guideline. The EFLM EUG now provides a total of 65 graded recommendations in its seven sections. The assessment and grading by laboratory professionals is a new approach where reliability and consistency of laboratory examination-related evidence is assessed, for use in clinical diagnostic or prognostic outcomes. The EUG 2023 discusses medical diagnostics of urinary tract infections (UTI) and kidney disease among different patient populations as its major topics. International clinical guidelines on these provided important backgrounds, as published, e.g., by the European Urology Association [5], and the Kidney Disease Improving Global Outcomes initiative [6]. To a lesser extent, other diseases were approached mostly at a screening level if the discussed measurements are used also for other purposes, such as detection of haematuria in urothelial cancers, or proteinuria or albuminuria in pregnancy. It is obvious that a shared laboratory expertise is needed to recommend criteria for qualified testing strategies in urinalysis, adequate preanalytical processes, combination of different analytical results in points-of-care, general laboratories, and specialised laboratories, as well as relevant clinical interpretations. The established EFLM TFG-U is a multidisciplinary expert group that could benefit from special knowledge of four clinical chemists and four clinical microbiologists representing several European countries that were devoted to this task despite the COVID-19 pandemic in Europe. The EFLM TFG-U group received remarkable number of comments and suggestions for improvement into the primary draft distributed for public consultation to the National Societies of the EFLM and other stakeholders in the spring 2023. The provided 245 comments and responses to them are electronically available as Supplemental material to the guideline text. The Introduction transparently describes the details of voting among the National Societies of the EFLM. Out of 41 voting EFLM Member Societies, 28 countries replied with positive votes and 1 with negative vote – the EUG 2023 recommendations can thus be considered officially as an approved EFLM guideline. Moreover, the Guidelines Subcommittee of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) provided a public consultation for their members resulting in endorsement of the key clinical microbiology-related Sections 1, 3 and 7 of the EUG by the ESCMID. The result of this work is a landmark document for the community of laborat -Abstract Truncated-

Evaluation of the draft guidelines proposed by EMA and FDA for the clinical diagnosis of acute uncomplicated cystitis in women

Usefulness and problems of the urinary tract infection criteria for evaluating drug efficacy for complicated urinary tract infections

Executive Summary: International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases

Linguistic and clinical validation of the acute cystitis symptom score in German-speaking Swiss women with acute cystitis

EFLM European Urinalysis Guideline

The Improving Outcomes of UTI Management in Long-Term Care Project (IOU) Consensus Guidelines for the Diagnosis of Uncomplicated Cystitis in Nursing Home Residents

The 2017 Update of the German Clinical Guideline on Epidemiology, Diagnostics, Therapy, Prevention, and Management of Uncomplicated Urinary Tract Infections in Adult Patients: Part 1

Situation analysis of guidelines for prevention of catheter-associated urinary tract infections

A critical review of recent clinical practice guidelines for pediatric urinary tract infection

Clinical guidelines of UTIs in children: quality appraisal with AGREE II and recommendations analysis

European Association of Urology Guidelines on Urological Infections: Summary of the 2024 Guidelines

[Epidemiology, diagnostics, therapy, prevention and management of uncomplicated bacterial outpatient acquired urinary tract infections in adult patients : Update 2017 of the interdisciplinary AWMF S3 guideline]

The 2017 Update of the German Clinical Guideline on Epidemiology, Diagnostics, Therapy, Prevention, and Management of Uncomplicated Urinary Tract Infections in Adult Patients. Part II: Therapy and Prevention

996 Electronic Aid to Diagnosis and Management of Childhood UTI: Based on Current UK (NICE) Guidelines

Treatment Patterns and Adherence to Guidelines for Uncomplicated Urinary Tract Infection in Germany: A Retrospective Cohort Study

[Antibiotic prophylaxis in urodynamics: Clinical practice guidelines using a formal consensus method]

Guidelines for the management of male urinary tract infections in primary care: a lack of international consensus-a systematic review of the literature

Urinary tract infection management – do the guidelines agree?

Review of clinical guidelines for the diagnosis, treatment and prevention of urinary tract infection in children

EAU Guidelines on Assessment and Nonsurgical Management of Urinary Incontinence

Guideline of guidelines: management of recurrent urinary tract infections in women